Skip to main content
. 2016 Sep 30;11(1):154–157. doi: 10.1177/1557988316671459

Table 1.

Characteristics of 100 YouTube.com Videos on Prostate Cancer.

Total (N = 100) Video upload source
p
Consumer, n = 45 Medical or government professional, n = 30 News source, n = 16 Commercial media or advertisement, n = 9
Video characteristics
Video, number of views
 Mean (SD) 502787.7 (1887118.6) 562956.2 (2022503.2) 575585.0 (2244817.9) 411109.5 (1276715.8) 122271.0 (169943.7) .44
 95% CI [132919.3, 872656.1] [0.0, 1153879.4] [0.0, 1378868.0] [0.0, 1036688.7] [11243.2, 233298.8]
 Range 34,004-13,312,255 34,004-1,331,225 34,542-12,286,309 39,996-5,195,332 34,320-56,992
Video length in minutes
 Mean (SD) 7.9 (13.3) 5.6 (7.9) 11.8 (19.8) 8.9 (12.7) 4.8 (3.3) .30
 95% CI [5.9, 10.5] [3.3, 7.9] [4.7, 18.9] [2.7, 15.1] [2.6, 7.0]
 Range 0.4-76.1 0.4-45.0 1.1-76.1 2.1-53.3 0.5-9.0
Video, number of “likes”
 Mean (SD) 1387.5 (8840.6) 516.2 (1334.4) 329.7 (913.7) 6529.9 (21801.6) 127.8 (111.0) .41
 95% CI [0, 3119.7] [126.3, 906.1] [2.7, 656.7] [0, 17256.6] [55.3, 200.3]
 Range 0-87,810 0-7,276 0-4,992 37-87,810 1-296
Video, number of “dislikes”
 Mean (SD) 102.2 (466.1) 135.3 (624.7) 85.4 (328.7) 88.6 (266.9) 16.7 (34.2) .25
 95% CI [10.8, 193.6] [0, 317.8] [0, 203.0] [0, 219.4] [0, 39.0]
 Range 0-4,202 0-4,202 0-1,795 2-1,086 0-106
Video content,a n (%)
 Purpose to provide information 78 (78.0) 29 (64.4) 30 (100.0) 15 (93.8) 4 (44.4) <.001
PSA, n (%)
Testing and routine screening 26 (26.0) 15 (33.3) 7 (23.3) 4 (25.0) 0 (0.0) .21
Encourages test 12 (12.0) 4 (8.9) 1 (3.3) 3 (18.8) 4 (44.4) .01
Test required 3 (3.0) 2 (4.4) 0 (0.0) 0 (0.0) 1 (11.1) .29
Pain associated 3 (3.0) 0 (0.0) 2 (6.7) 0 (0.0) 1 (11.1) .15
Anxiety/fear of diagnosis/screening 8 (8.0) 3 (6.7) 2 (6.7) 1 (6.3) 2 (22.2) .44
Prostate cancer, n (%)
Risk factors 16 (16.0) 6 (13.3) 7 (23.3) 3 (18.8) 0 (0.0) .36
Treatment 51 (51.0) 21 (46.7) 14 (46.7) 12 (75.0) 4 (44.4) .22
Prevention 18 (18.0) 8 (17.8) 6 (20.0) 4 (25.0) 0 (0.0) .46

Note. CI = confidence interval; PSA = prostate-specific antigen.

a

Categories overlap and do not add up to 100%.